Disorders of Fatty Acid Oxidation (FAOD) Panel
Use
The Disorders of Fatty Acid Oxidation (FAOD) Panel is intended for individuals who exhibit clinical symptoms or have a suspected diagnosis of fatty acid oxidation disorders. It is also suitable for those who show abnormal acylcarnitine profiles indicative of such disorders. By providing comprehensive genetic analysis, this test aids in confirming diagnosis and informing treatment strategies for patients with these metabolic conditions.
Special Instructions
Exome platform allows for blood, DNA, buccal, saliva, or tissue specimens, while the genome platform requires blood or DNA specimens. Orders can be submitted using the provided test requisition form or online through the myPrevent portal.
Limitations
This test was developed and validated by PreventionGenetics according to applicable standards, but has not been approved by the FDA. Results should be interpreted in the context of clinical findings and family history. Limitations include potential inability to detect all variants, especially in cases of technical challenges, such as low-quality samples or partial gene coverage.
New York Approved
Methodology
NGS
Biomarkers
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided